LncRNA WDFY3-AS2 was significantly highly expressed in ovarian cancer tissues and promoted the sensitivity of ovarian cancer cells to cisplatin by competitive adsorption of miR-139-5p [113]. Here, WDFY3 is linked to ovarian carcinoma.